10 results  1 of 1 

1 Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity
Jörg U. Schmohl, Martin Felices, Felix Oh, Alexander J. Lenvik, Aaron M. Lebeau, Jayanth Panyam, Jeffrey S. Miller, Daniel A. Vallera
Cancer Res Treat.2017;49(4):1140-1152.   Published online 2017 February 20     DOI: http://dx.doi.org/10.4143/crt.2016.491
      
2 Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
Wanlu Li, Mi-Ra Lee, EunHee Choi, Mee-Yon Cho
J Pathol Transl Med.2017;51(1):17-23.   Published online 2016 December 15     DOI: http://dx.doi.org/10.4132/jptm.2016.09.23
      
3 Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer
Sung Jeep Kim, Yong Seok Kim, Eun Duok Jang, Kyung Jin Seo, Jeong Soo Kim
J Breast Cancer.2015;18(4):347-355.   Published online 2015 December 23     DOI: http://dx.doi.org/10.4048/jbc.2015.18.4.347
      
4 Granulocyte Colony-Stimulating Factor for Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study of Iranian Patients
Nasibeh Amirzagar, Shahriar Nafissi, Abbas Tafakhori, Amirhossein Modabbernia, Aliakbar Amirzargar, Majid Ghaffarpour, Bahaddin Siroos, Mohammad Hossein Harirchian
J Clin Neurol.2015;11(2):164-171.   Published online 2015 March 26     DOI: http://dx.doi.org/10.3988/jcn.2015.11.2.164
      
5 Comparison of putative circulating cancer stem cell detection between the hepatic portal system and peripheral blood in colorectal cancer patients
Byung Soo Park, Seok Yun Jung, Sang Mo Kwon, Jae Ho Bae, Sun Min Lee, Dong Hoon Shin, Gyung Mo Son
Ann Surg Treat Res.2014;87(5):232-238.   Published online 2014 October 24     DOI: http://dx.doi.org/10.4174/astr.2014.87.5.232
      
6 Overexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast Cancer
Maurizio Di Bonito, Monica Cantile, Francesca Collina, Giosuè Scognamiglio, Margherita Cerrone, Elvira La Mantia, Antonio Barbato, Giuseppina Liguori, Gerardo Botti
J Breast Cancer.2012;15(2):162-171.   Published online 2012 June 28     DOI: http://dx.doi.org/10.4048/jbc.2012.15.2.162
      
7 Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis
Maurizio Di Bonito, Francesca Collina, Monica Cantile, Rosalba Camerlingo, Margherita Cerrone, Laura Marra, Giuseppina Liguori, Giuseppe Pirozzi, Gerardo Botti
J Breast Cancer.2012;15(1):15-23.   Published online 2012 March 28     DOI: http://dx.doi.org/10.4048/jbc.2012.15.1.15
      
8 Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells
Hee Yi, Hee-Jung Cho, Soo-Min Cho, Kyul Jo, Jin-A Park, Soo-Han Lee, Byung-Joon Chang, Jin-Suk Kim, Ho-Chul Shin
Korean J Physiol Pharmacol.2012;16(1):11-16.   Published online 2012 February 28     DOI: http://dx.doi.org/10.4196/kjpp.2012.16.1.11
      
9 Significance of CD133 as a cancer stem cell markers focusing on the tumorigenicity of pancreatic cancer cell lines
Hyun Joo Lee, Dong Do You, Dong Wook Choi, Young Sil Choi, Seong Joo Kim, Yong Sung Won, Hyoun Jong Moon
J Korean Surg Soc.2011;81(4):263-270.   Published online 2011 October 28     DOI: http://dx.doi.org/10.4174/jkss.2011.81.4.263
   
10 CD44 and CD133 as Cancer Stem Cell Markers for Gastric Cancer
Hyun-Joo Lee, Young-Sil Choi, Sung-Joo Kim, Hyoun Jong Moon
J Gastric Cancer.2010;10(3):99-105.   Published online 2010 September 30     DOI: http://dx.doi.org/10.5230/jgc.2010.10.3.99
      

 1 of 1